4.8 Article

Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

RNAi: a potential new class of therapeutic for human genetic disease

Attila A. Seyhan

HUMAN GENETICS (2011)

Article Neurosciences

Role of Guanylyl Cyclase Modulation in Mouse Cone Phototransduction

Keisuke Sakurai et al.

JOURNAL OF NEUROSCIENCE (2011)

Article Biotechnology & Applied Microbiology

Suppression and Replacement Gene Therapy for Autosomal Dominant Disease in a Murine Model of Dominant Retinitis Pigmentosa

Sophia Millington-Ward et al.

MOLECULAR THERAPY (2011)

Review Genetics & Heredity

Current prospects for RNA interference-based therapies

Beverly L. Davidson et al.

NATURE REVIEWS GENETICS (2011)

Article Biochemistry & Molecular Biology

AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins

A. Georgiadis et al.

GENE THERAPY (2010)

Review Biotechnology & Applied Microbiology

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

Aimee L. Jackson et al.

NATURE REVIEWS DRUG DISCOVERY (2010)

Article Biotechnology & Applied Microbiology

Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy

Naomi Chadderton et al.

MOLECULAR THERAPY (2009)

Article Ophthalmology

Hereditary retinal disease

Peter Goodwin

CURRENT OPINION IN OPHTHALMOLOGY (2008)

Article Biochemistry & Molecular Biology

A Role for GCAP2 in Regulating the Photoresponse GUANYLYL CYCLASE ACTIVATION AND ROD ELECTROPHYSIOLOGY IN GUCA1B KNOCK-OUT MICE

Clint L. Makino et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biotechnology & Applied Microbiology

Self-complementary AAV vectors; Advances and applications

Douglas M. McCarty

MOLECULAR THERAPY (2008)

Article Multidisciplinary Sciences

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

Mark E. Kleinman et al.

NATURE (2008)

Review Neurosciences

Barriers for retinal gene therapy: Separating fact from fiction

Rajendra Kumar-Singh

VISION RESEARCH (2008)

Review Biochemistry & Molecular Biology

Gene therapy progress and prospects: the eye

J. W. B. Bainbridge et al.

GENE THERAPY (2006)

Article Biotechnology & Applied Microbiology

Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection

Samuel G. Jacobson et al.

MOLECULAR THERAPY (2006)

Article Biochemistry & Molecular Biology

Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1

J Shen et al.

GENE THERAPY (2006)

Article Ophthalmology

A novel GCAP1 missense mutation (L151F) in a large family with autosomal dominant cone-rod dystrophy (adCORD)

I Sokal et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)

Article Multidisciplinary Sciences

Guanylate cyclase-activating protein (GCAP) 1 rescues cone recovery kinetics in GCAPl/GCAP2 knockout mice

ME Pennesi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

JY Yu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Biochemistry & Molecular Biology

GCAP1 rescues rod photoreceptor response in GCAP1/GCAP2 knockout mice

KA Howes et al.

EMBO JOURNAL (2002)

Article Neurosciences

Characterization of retinal guanylate cyclase-activating protein 3 (GCAP3) from zebrafish to man

Y Imanishi et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2002)

Article Multidisciplinary Sciences

Role of guanylate cyclase-activating proteins (GCAPs) in setting the flash sensitivity of rod photoreceptors

A Mendez et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)